{{Rsnum
|rsid=7186128
|Chromosome=16
|position=16864058
|Orientation=plus
|GMAF=0.2847
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 47.8 | 46.9 | 5.3
| HCB | 64.2 | 32.8 | 2.9
| JPT | 55.8 | 38.1 | 6.2
| YRI | 53.1 | 39.5 | 7.5
| ASW | 50.9 | 36.8 | 12.3
| CHB | 64.2 | 32.8 | 2.9
| CHD | 58.7 | 35.8 | 5.5
| GIH | 42.6 | 45.5 | 11.9
| LWK | 40.0 | 48.2 | 11.8
| MEX | 43.1 | 41.4 | 15.5
| MKK | 32.7 | 52.6 | 14.7
| TSI | 51.0 | 40.2 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23478653
  |Trait=Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
  |Title=A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
  |RiskAllele=G
  |Pval=4E-7
  |OR=2.50
  |ORtxt=[1.70-3.50]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}